NCT03481972View on ClinicalTrials.gov

A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by Transthyretin

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

January 18, 2023

Study Completion Date

June 22, 2023

Conditions
TTR Cardiac Amyloidosis
Interventions
DRUG

Doxycycline and tauroursodeoxycholic acid

doxycicline and tauroursodeoxycholic acid

DRUG

Standard of care

Standard of care

Trial Locations (1)

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

NCT03481972 - A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by Transthyretin | Biotech Hunter | Biotech Hunter